Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations.

Nature communications·2026
Same author

Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladder.

The Journal of pathology·2026
Same author

Stability-Based Machine Learning Identifies a Minimal Two-Protein Serum Signature for Early Silicosis.

Journal of proteome research·2026
Same author

Dichotomous role of CD47-SIRP<i>α</i> axis: Leveraging opposing functions in phagocytic resistance and transport assistance for enhanced nanocarrier biocompatibility and tumor penetration.

Acta pharmaceutica Sinica. B·2026
Same author

Long-term survival and the critical role of competing risks in pneumoconiosis: a large-scale retrospective cohort study.

Frontiers in public health·2026
Same author

Targeting Ferroptosis in Sensorineural Hearing Loss: A Mechanistic Review of Therapeutic Opportunities.

Current issues in molecular biology·2025

相关实验视频

Updated: May 25, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.8K

在构建生物相容纳米载体方面的进展.

Xuehui Duan1, Xinlei Chu1, Yan Du1

  • 1School of Pharmaceutical Sciences & Institute of Materia Medica, Medical Science and Technology Innovation Center, National Key Laboratory of Advanced Drug Delivery System, Key Laboratory for Biotechnology Drugs of National Health Commission, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.

Drug delivery and translational research
|June 18, 2025
PubMed
概括
此摘要是机器生成的。

设计生物相容纳米载体对于药物输送成功至关重要. 本综述分析了惰性材料,聚合物工程和仿生方法,以优化纳米载体的安全性和疗效,用于临床转化.

关键词:
生物相容性 生物相容性生物模拟策略 生物模拟策略不活动的运输商.纳米载体的使用方法聚合物修饰的聚合物修饰

更多相关视频

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

8.0K

相关实验视频

Last Updated: May 25, 2026

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
09:47

Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes

Published on: February 19, 2016

9.8K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

16.0K
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

8.0K

科学领域:

  • 生物材料科学 生物材料科学
  • 纳米技术 纳米技术
  • 药物运输 药物运输 药物运输

背景情况:

  • 有效的药物纳米载体必须尽量减少不良的生物相互作用,如免疫激活和细胞毒性.
  • 优越的生物相容性对于纳米药物的临床成功至关重要.
  • 现有的审查通常侧重于治疗应用,对生物相容性优化进行有限的系统分析.

研究的目的:

  • 系统地审查和分析提高纳米载体生物相容性的策略.
  • 在纳米医学中为生物相容性增强选择最佳方法提供指导.
  • 为了弥合关于纳米载体设计生物相容性优化的文献上的差距.

主要方法:

  • 审查了三个主要方法:基于惰性材料的框架,聚合物表面工程和生物模拟功能化.
  • 评估常用材料的结构设计和生物机制.
  • 分析每个生物相容性增强策略的优点和局限性.

主要成果:

  • 确定了构建生物相容纳米载体的三个关键策略.
  • 阐明了这些策略如何利用材料特性和生物相互作用来调节生物相容性.
  • 提供了对每个方法的优点和弱点的比较分析.

结论:

  • 综合了生物相容纳米载体开发的当前进展.
  • 为改善纳米医学研究和临床转化提供了可操作的见解.
  • 强调了战略生物相容性优化对纳米载体设计的重要性.